Blog

On January 29, 2025, the Federal Open Market Committee paused its recent spate of interest rate cuts, leaving the overnight borrowing rate at 4.25%-4.5%. The move comes after three consecutive

On day one as the 47th President of the United States, Donald Trump signed an executive order mandating all federal employees to return to the office for work “as soon as practicable.”

Crane Company (NYSE: CR) stock is up more than 100% since its separation from Crane NXT (NYSE: CXT) and can continue to rise by another triple-digit. The rise in stock price is driven by the

Giants in the tech industry are reporting earnings for the first time in 2025 to much anticipation. Investors have been eager to hear how hyperscalers will respond to DeepSeek, which shook

While the image of self-driving cars effortlessly navigating city streets dominates headlines, a quieter yet equally transformative revolution is underway within the confines of factories and

Now that Donald Trump is starting his second term as President, reviewing sector performance during his first term is an interesting exercise. Some of the results may come as a surprise

Shares of Nebius Group (NASDAQ: NBIS) took a nosedive on Monday, plummeting nearly 40% following the release of DeepSeek’s latest AI model. The shockwave of this announcement caused fear-driven

Gold prices repeatedly reached new highs in 2024 and are again nearing record levels. Multiple factors, including rising geopolitical tensions and the consequent demand for safe-haven assets

Nike Inc (NYSE: NKE) shares have been continuing to consolidate after a painful three-year downtrend that finally looks to be running out of steam. 2021's all-time high seems a long way away

Uber Technologies Inc. (NYSE: UBER) shares have demonstrated solid resilience in recent weeks as they continue gaining momentum after a choppy 2024. While the stock is still some way off last

AbbVie (NYSE: ABBV) is a high-quality, dividend-growing pharmaceutical company with a robust outlook for growth: now is a good time to load up on shares. Fears of Humira’s patent cliff are

“Turnaround” is a magic word for investors looking to get into a stock at cheap valuations. It’s a key justification for entering stocks that have been left for dead. It's also a term that gets

Whirlpool’s (NYSE: WHR) FQ4 2024 results and guidance for 2025 were lackluster, but they did not provide any real reason for the stock price to sell off the way it did. Tepid relative to

Commvault Systems (NASDAQ: CVLT) share price trended higher in 2023 and 2024, gaining more than 150% at the movement's peak, and can continue to trend higher in 2025 and beyond. The reason is

Two massive developments have come out in recent weeks surrounding the AI investment landscape. The first came on Jan. 21, with the announcement of The Stargate Project. It looks to invest $500

The market has been worried about the potential implications of President Trump's new tariffs on some of the United States’ biggest trading partners. The latest announcements were made for

Starbucks' (NASDAQ: SBUX) outlook is improving, with Brian Niccol at the helm, and new all-time highs will likely be achieved by the end of this year. Now, more than a full quarter into the

Saying that growth investing is all about short-term profits is a misnomer. Just ask anyone who has spent the last 20 years invested in Apple Inc. (NASDAQ: AAPL) or Amazon Inc. (NASDAQ: AMZN) if

Meta Platforms' (NASDAQ: META) uptrend will continue because the business is evolving into an enduring, blue-chip consumer technology leader akin to Apple (NASDAQ: AAPL). Among the highlights

Microsoft's (NASDAQ: MSFT) stock price plunged more than 6% following its FQ2 earnings report and broke the uptrend, but it doesn’t matter. The results were strong, and the long-term opportunity

You can't mention value investing without mentioning legendary value investor Warren Buffett. Buffett. You may have heard one of his most famous quotes: "Price is what you pay. Value is what you

Clinical-stage biopharmaceutical company Tonix Pharmaceuticals (NASDAQ: TNXP) is gaining significant attention from investors and market participants. The company develops therapies for